Home Overview Press Room Blog Publications For Students about us
Search

About Assisted Reproduction


Most assisted reproductive technologies (ART) are used to treat infertility. Others are used when there are no fertility problems. Embryo screening or pre-implantation genetic diagnosis, for example, is used in order to prevent the births of children with specific genetic characteristics.

In vitro fertilization (IVF) refers to assisted reproduction procedures in which sperm and eggs are joined outside a woman's body. Women undergoing IVF are given hormonal drugs to promote the development of multiple eggs, which are retrieved with a minor surgical procedure. The eggs are mixed with sperm; some of those that fertilize are then transferred to the woman's uterus.

IVF has been in use since 1978 and has resulted in about a million pregnancies worldwide. A number of IVF-related techniques (for example, intracytoplasmic sperm injection) and practices (for example, surrogacy) have been introduced since then. In the United States alone, the assisted reproduction business is estimated to create over $4 billion in revenues a year.

Research on the risks associated with ART is notoriously inadequate. There have been few follow-up studies either on women who have used ARTs or their children. The United States is also known for having few laws governing assisted reproduction and little oversight of ART facilities.

 



Whither personal genomics?by Jesse ReynoldsBiopolitical TimesJanuary 29th, 2010Three companies offer contrasting examples of where the fledgling industry goes from here.
In the womb of controversyby Jaya MenonThe Times of IndiaJanuary 25th, 2010The US consulate in Chennai has tightened its visa processing norms, particularly for couples coming to the city for fertility treatment.
Legal Updates: DNA Databases, Human Gene Patents, Octomom’s doctorby Osagie ObasogieBiopolitical TimesJanuary 17th, 2010The past few weeks have seen a number of legal developments involving reproductive and genetic technologies.
Surrogacy Battles Expose Uneven Legal Landscapeby Nathan KoppelWall Street JournalJanuary 15th, 2010Surrogacy remains a relatively uncommon pathway to parenthood, in part because it still rests on a somewhat shaky legal ground in parts of the country
IVF babies ‘risk major diseases’by Jonathan LeakeThe TimesJanuary 10th, 2010Scientists have discovered that the DNA of babies conceived through IVF differs from that of other children, putting them at greater risk of diseases such as diabetes and obesity later in life.
Nudging the Discourse?by Pete ShanksBiopolitical TimesJanuary 8th, 2010The Popular Mechanics article misleadingly titled "How to Create a Designer Baby" includes a call for regulation of assisted reproduction.
California board accuses octuplets doctor of negligenceby Kimi YoshinoLos Angeles TimesJanuary 8th, 2010Dr. Michael Kamrava stockpiled embryos and failed to assess Nadya Suleman's mental health, panel says.
Calls for Regulating Surrogacy in the New York Timesby Jesse ReynoldsBiopolitical TimesJanuary 5th, 2010The paper of record ran four opinions online, each calling for greater oversight of commercial surrogacy.
Beauty, Brains, and Eggs [Video][Quotes CGS's Marcy Darnovsky]KCETDecember 18th, 2009Los Angeles's public television station examines the big and mostly unregulated business of egg donation.
UK Feminist Campaign: No2Eggsploitationby Marcy DarnovskyBiopolitical TimesDecember 15th, 2009The UK's fertility watchdog agency is considering revoking the rule that limits payments to women who provide eggs for other people's IVF treatment. A network of British feminists objects.
Displaying 1-10 of 328  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.625.0819 • (F) 1.510.625.0874